Personal information

No personal information available

Activities

Employment (2)

Massachusetts Institute of Technology: Cambridge, US

2024-06-01 to present | Postdoctoral Fellow (Chemistry)
Employment
Source: Self-asserted source
Michael Desgagné

Université de Sherbrooke: Sherbrooke, CA

2018-01-03 to 2024-05-31 | Graduate student (Pharmacology-Physiology)
Employment
Source: Self-asserted source
Michael Desgagné

Works (10)

Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics

Angewandte Chemie International Edition
2024-11-18 | Journal article
Contributors: Michael Desgagné; Magali Chartier; Camille Lagard; Sára Ferková; Mathieu Choquette; Jean‐Michel Longpré; Jérôme Côté; Pierre‐Luc Boudreault; Philippe Sarret
Source: check_circle
Crossref

Development of Macrocyclic Neurotensin Receptor Type 2 (NTS2) Opioid‐Free Analgesics

Angewandte Chemie
2024-11-18 | Journal article
Contributors: Michael Desgagné; Magali Chartier; Camille Lagard; Sára Ferková; Mathieu Choquette; Jean‐Michel Longpré; Jérôme Côté; Pierre‐Luc Boudreault; Philippe Sarret
Source: check_circle
Crossref

Rational In Silico Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 Subpocket

Journal of Medicinal Chemistry
2024-08-08 | Journal article
Contributors: Michael Desgagné; Antoine Désilets; Sára Ferková; Matthieu Lepage; Olivier Perreault; Alexandre Joushomme; Gabriel Lemieux; Walid Guerrab; Ulrike Froehlich; Christian Comeau et al.
Source: check_circle
Crossref

Insights on Structure–Passive Permeability Relationship in Pyrrole and Furan-Containing Macrocycles

Journal of Medicinal Chemistry
2024-03-14 | Journal article
Contributors: Huy M. Ly; Michael Desgagné; Duc Tai Nguyen; Christian Comeau; Ulrike Froehlich; Éric Marsault; Pierre-Luc Boudreault
Source: check_circle
Crossref

Opening the amino acid toolbox for peptide‐based NTS2‐selective ligands as promising lead compounds for pain management

Journal of Peptide Science
2023-06 | Journal article
Contributors: Santo Previti; Michael Desgagné; Dirk Tourwé; Florine Cavelier; Philippe Sarret; Steven Ballet
Source: check_circle
Crossref

The Therapeutic Value of Solanum Steroidal (Glyco)Alkaloids: A 10-Year Comprehensive Review

Molecules
2023-06-23 | Journal article
Contributors: Julien A. Delbrouck; Michael Desgagné; Christian Comeau; Kamal Bouarab; François Malouin; Pierre-Luc Boudreault
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Signaling Modulation via Minimal C-Terminal Modifications of Apelin-13

ACS Pharmacology & Translational Science
2023-02-10 | Journal article
Part of ISSN: 2575-9108
Part of ISSN: 2575-9108
Contributors: Léa Théroux; Robin Van Den Hauwe; Kien Trân; Justin Fournier; Michael Desgagné; Nathan Meneboo; Alexis Lavallée; Ulrike Fröhlich; Jérôme Côté; Charlie Hollanders et al.
Source: Self-asserted source
Michael Desgagné

Efficient Fmoc-Protected Amino Ester Hydrolysis Using Green Calcium(II) Iodide as a Protective Agent

Molecules
2022-04-27 | Journal article
Contributors: Renaud Binette; Michael Desgagné; Camille Theaud; Pierre-Luc Boudreault
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Pharmacodynamic and pharmacokinetic profiles of a neurotensin receptor type 2 (NTS2) analgesic macrocyclic analog

Biomedicine & Pharmacotherapy
2021-07 | Journal article
Part of ISSN: 0753-3322
Source: Self-asserted source
Michael Desgagné

Design, Structural Optimization, and Characterization of the First Selective Macrocyclic Neurotensin Receptor Type 2 Non-opioid Analgesic.

Journal of medicinal chemistry
2021-02-04 | Journal article
Source: Self-asserted source
Michael Desgagné